Evaluation of Retinal Structure With High Resolution Optical Coherence Tomography (OCT)

November 28, 2023 updated by: Sebastian Wolf

Evaluation of Retinal Structure With High Resolution OCT

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Comparison of different OCT instruments to assess retinal thickness, correlation to fluorescein angiography, and visual outcome after therapy with anti-VEGF therapy

Study Type

Observational

Enrollment (Actual)

700

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Bern, Switzerland
        • Klinik und Poliklinik für Augenheilkunde, University Bern
      • Bern, Switzerland, 3010
        • Dep. Ophthalmology, University Hospital Bern

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

healthy subjects and patients with macular diseases

Description

Inclusion Criteria:

  • Macular disease
  • Healthy subjects

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Healthy volunteers
Other: Examination with an OCT device
2
CSME secondary to diabetic retinopathy
3
ARMD with CNV before and after therapy
Other: Examination with an OCT device
4
ARMD atrophic
Other: Examination with an OCT device
5
Retinal vein occlusion
Other: Examination with an OCT device
6
retinitis pigmentosa
Other: Examination with an OCT device
7
vitreoretinal proliferation
Other: Examination with an OCT device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Integrity of retinal layers
Time Frame: End of study
End of study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sebastian Wolf

Collaborators

University of Bern

Investigators

  • Principal Investigator: Sebastian Wolf, MD, PhD, University of Bern
  • Study Director: Sebastian Wolf, MD PhD, University of Bern

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2007

Primary Completion (Actual)

November 27, 2023

Study Completion (Actual)

November 28, 2023

Study Registration Dates

First Submitted

November 26, 2007

First Submitted That Met QC Criteria

November 26, 2007

First Posted (Estimated)

November 27, 2007

Study Record Updates

Last Update Posted (Actual)

November 29, 2023

Last Update Submitted That Met QC Criteria

November 28, 2023

Last Verified

November 1, 2023

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KEK 044/07

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Macular Edema

Clinical Trials on Examination with an OCT device

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe